Novo Nordisk is partnering with telehealth providers Hims & Hers, Ro, and Life MD to make its weight loss drug Wegovy more accessible. Shares soar as Wegovy becomes readily available.
Hims & Hers Health shares skyrocketed nearly 30% in premarket trading following a groundbreaking partnership with Novo Nordisk to sell the weight loss drug Wegovy. Discover what this means for investors!